Recent Updates
Recently added Catalysts
LMAT

LeMaitre to Present at Upcoming Investor Conferences

Key Takeaway: BURLINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences. JJ Pellegrino, Chief Financial Officer, will present at the UBS Global Healthcare Conference on Monday, May 23

Conference Participation Details

UBS Global Healthcare Conference
Date: November 11, 2025
Time: 8:45 a.m. ET
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Full Press Release Details

BURLINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences.
JJ Pellegrino, Chief Financial Officer, will present at the UBS Global Healthcare Conference on Monday, May 23, 2022 at the Lotte New York Palace in New York City. The company’s presentation is scheduled at 2:00 PM ET.
David Roberts, President, will present at the Jefferies in the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at the Marriott Marquis in New York City. The company’s presentation is scheduled at 9:30 AM ET.
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

Contact Data

LeMaitre Vascular, Inc.

Contact

With a Reader Account, it's easy to send email directly to the contact for this release. Sign up today for your free Reader Account!
Already have an account? Log in here.
Last updated: May 16, 2022